# Topharman Shandong Co., Ltd. – FDA Inspection, May 17, 2024

Source: https://www.keypedia.com/records/fda_inspections/topharman-shandong-co-ltd/dbeabf66-f709-4e81-8b78-f6699ec7bd18
Source feed: FDA_Inspections

> FDA inspection 1241491 of Topharman Shandong Co., Ltd., May 17, 2024. Classification: Voluntary Action Indicated (VAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1241491
- Company Name: Topharman Shandong Co., Ltd.
- Inspection Date: 2024-05-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 988743 - 2016-09-28

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/syeda-n-mahazabin/54af6f8a-6d41-4399-b58e-a2d88fd2d7bf)

Company: https://www.keypedia.com/companies/topharman-shandong-co-ltd/999f8c9e-e7f3-4d61-8974-399112bfa25c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c